| Gastric Carcinoma studied in …STUDIED_INderived200 of 586show all (up to 200) |
|---|
| → studied in | NCT02465060Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06203600Phase 2/Phase 3 · recruiting Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07529808Phase 1/Phase 2 · recruiting Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03030404completed Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition to Gastric Cancer · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Hereditary Gastric Diffuse Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06586957Phase 1 · recruiting A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07277413Phase 1 · recruiting A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06123338Phase 2 · recruiting A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06882746Phase 1 · terminated A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04044859Phase 1 · active not recruiting ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS) · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06253650Phase 2 · recruiting Adjuvant TRastuzumab Deruxtecan for HER2-positive Gastroesophageal Cancer With Persistence of miNImal Residual Disease · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | HER2-Positive Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07315750Phase 3 · recruiting A Study of Disitamab Vedotin Combined With Trastuzumab and Tislelizumab Versus Chemotherapy Combined With Trastuzumab With or Without Pembrolizumab in HER2-high Expression Advanced Gastric or Gastroesophageal Junction Adenocarcinoma. · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07835087NA · recruiting Image-Guided Platform-Assisted Sentinel Lymph Node Retrieval in Early Gastric Cancer · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Early Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03776487Phase 2 · active not recruiting Nivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04152499Phase 1/Phase 2 · active not recruiting Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01) · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06324357Phase 1/Phase 2 · recruiting Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06730373Phase 2 · recruiting First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2) · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07429487NA · recruiting Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02782949Phase 2 · active not recruiting Curcumin in Preventing Gastric Cancer in Patients With Chronic Atrophic Gastritis or Gastric Intestinal Metaplasia · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04111172Phase 2 · suspended A Vaccine (Ad5.F35-hGCC-PADRE) for the Treatment of Gastrointestinal Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04248452Phase 3 · active not recruiting Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05059444recruiting ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05482516Phase 3 · recruiting Evaluating Novel Therapies in ctDNA Positive GI Cancers · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07615374NA · recruiting Laparoscopic-endoscopic Surgery Assisted Sentinel Lymph Node Navigation Surgery for Early Gastric Cancer · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Early Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05365581Phase 1 · recruiting A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06764875Phase 3 · recruiting A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | HER2-Positive Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07673887Phase 3 · recruiting A Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07714538recruiting Breath Research Narrow Validation for Gastrointestinal Cancer Detection · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06266299Phase 1 · recruiting A Study of KK2269 in Adult Participants With Solid Tumors · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07000253Phase 2 · recruiting Timing of Comprehensive Local Treatment After First-Line Systemic Therapy in Oligometastatic Esophageal or Gastric Adenocarcinoma · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05715931Phase 2 · active not recruiting Perioperative Chemotherapy Plus Trastuzumab Plus Toripalimab in HER2 Positive Locally Advanced Gastric or Esophagogastric Junction Adenocarcinoma · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07282912Phase 2 · recruiting Trial Comparing Standard of Care Therapy With and Without Sequential Cytoreductive Intervention for Patients With Metastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA) Levels · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07808164recruiting ENPP1/cGAS (EG) and FAP Expression Profiles in Solid Tumors: An Immunohistochemical Study in a Vietnamese Cohort · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04704661Phase 1 · active not recruiting Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06364410Phase 1 · recruiting Testing the Combination of the Anticancer Drugs Trastuzumab Deruxtecan (DS-8201a) and Azenosertib (ZN-c3) in Patients With Stomach or Other Solid Tumors · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05677490Phase 3 · recruiting mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07803159not yet recruiting Frailty, Immunonutrition, Surgery Type, and Biologic Recovery in Elderly Gastric Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06995898NA · recruiting The Vanguard Study: Testing a New Way to Screen for Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07283939NA · recruiting Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07799649not yet recruiting ctDNA-MRD Monitoring After Neoadjuvant Therapy in Gastric Cancer With pCR or MPR · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04209686Phase 2 · completed Paclitaxel, Pembrolizumab and Olaparib in Previously Treated Advanced Gastric Adenocarcinoma · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06881043recruiting The Safety and Efficacy of Robotic Assisted Surgery Using Vessel Sealer Extend in Locally Advanced Gastric Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07486518recruiting A Multicentre Observational Cross-Sectional Study of The Gastric Precancerous Epithelial Pathway Using High-Definition Endoscopy And Histopathology In India · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06979895recruiting Investigating Multigene Methylation Dynamics in Treatment Response Surveillance for Gastric Cancer · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07544589Phase 1 · recruiting A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07791329Phase 2 · completed Sequential FDG-PET and miRNA as Biomarkers of Preoperative Treatment Strategy in LA Oesophago-Gastric Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04329494Phase 1 · recruiting PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07780968not yet recruiting Zanidatamab Outcomes and Lived Experiences in Advanced HER2+ GEA · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | HER2-Positive Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01882933Phase 3 · completed D2 Resection and HIPEC (Hyperthermic Intraperitoneal Chemoperfusion) in Locally Advanced Gastric Carcinoma · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07554521Phase 2 · recruiting A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Adenocarcinoma and Esophageal Squamous Cell Carcinoma in Racial and Ethnic Minority Patients in the United States · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07781319completed Early Gastric Cancer in the Spanish EURECCA Registry · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Early Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04147494early Phase 1 · active not recruiting Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04535401Phase 1 · active not recruiting Testing the Addition of an Anticancer Drug, BAY 1895344, to the Usual Chemotherapy With FOLFIRI in Advanced or Metastatic Cancers of the Stomach and Intestines · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06250036Phase 2 · suspended Zimberelimab Anti-PD1 +/- Domvanalimab in Resectable Mmrd Gastric Cancer · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06788548NA · recruiting Fluorescence Guided Laparoscopic-Endoscopic Cooperative Sentinel Lymph Node Navigation Surgery Strategy for Early Gastric Cancer（IDEAL Stage 2b） · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Early Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07581405Phase 2 · not yet recruiting GI-05: The Impact of Olanzapine Among Patients Receiving Neoadjuvant Chemotherapy for Gastric Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04410302recruiting Patient-Derived Xenografts to Reduce Cancer Health Disparities · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05269381Phase 1/Phase 2 · recruiting Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04550494Phase 2 · active not recruiting Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variations · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05203627NA · active not recruiting Telehealth for the Self-Management of Dietary Quality of Life in Patients After Stomach Cancer Surgery · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07001748Phase 2/Phase 3 · recruiting Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06846996recruiting Real-world Effectiveness and Safety of Trastuzumab Deruxtecan in Patients With Locally Advanced or Metastatic HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma in China · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | HER2-Positive Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07182149Phase 1 · recruiting A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04221893NA · recruiting Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05038098Phase 1 · not yet recruiting Magnetic Sentinel Lymph Node Mapping in Gastric Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06399757Phase 1/Phase 2 · active not recruiting A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06792435Phase 1/Phase 2 · active not recruiting XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies. · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07021066Phase 1 · active not recruiting Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid Tumors · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07699939Phase 2 · recruiting Perioperative HLX10 (Serplulimab) With S-1+Oxaliplatin (SOX) in Locally Advanced and PD-L1-Positive Gastric or Esophagogastric Junction Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07747688recruiting Retrospective Analysis of Early Gastric Cancer Patients Based on Prospective Clinical Dataset · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Early Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04460937Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Esophageal and Gastroesophageal Junction Cancers · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Cardia Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04491942Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03641313Phase 2 · active not recruiting Berzosertib and Irinotecan in Treating Patients With Progressive, Metastatic, or Unresectable TP53 Mutant Gastric or Gastroesophageal Junction Cancer · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06914687Phase 2 · active not recruiting Efficacy of Tirellizumab Combined With Oral, Intravenous and Abdominal Chemotherapy in Peritoneal Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02595424Phase 2 · active not recruiting Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05476796Phase 2 · active not recruiting Oxaliplatin ± Nivolumab in Combination With Trifluridine/Tipiracil or 5-fluorouracile in Frail Patients With Advanced, Recurrent or Metastatic Gastric, Oesophageal or Gastroesophageal Junction Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07724496recruiting Helicobacter Pylori Infection Status and Pathological Features for Predicting Gastric Cancer Biological Behavior and Prognosis: A Real-World Observational Study · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Early Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04164979Phase 2 · completed Ph II Study of Cabozantinib With Pembrolizumab in Metastatic Gastric and Gastroesophageal Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07522320active not recruiting Costs of Opportunistic Upper Gastrointestinal Endoscopy and the Economic Burden of Gastric Cancer Management · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07709767Phase 2 · not yet recruiting Conversion Therapy With Retlirafusp Alfa Plus Chemotherapy in Gastric or Gastroesophageal Junction Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04523818Phase 1 · active not recruiting Short-Course Chemoradiotherapy Followed by Chemotherapy for the Treatment of Resectable Gastric Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05041153early Phase 1 · active not recruiting Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adenocarcinoma · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05705492Phase 2 · recruiting Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07464756Phase 2 · recruiting SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07701681Phase 2 · not yet recruiting Sacituzumab Tirumotecan (Sac-TMT/SKB264) Plus Tagitanlimab (KL-A167) in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma and Gastric/Gastroesophageal Junction Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04840264Phase 2 · recruiting Docetaxel, Oxaliplatin and 5-FU for Gastric Cancer With Inoperable Malignant Bowel Obstruction · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07689292Phase 2 · not yet recruiting Sac-TMT Combined With Fruquintinib as Second-Line Treatment in Patients With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07692477not yet recruiting Molecular Characterization of Tumor-Microenvironment Interactions to Predict Drug Resistance in Gastric and GEJ Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06824363early Phase 1 · recruiting ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w/ARID1a Mu · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07621484Phase 2 · not yet recruiting HIPEC Priming Followed by Serplulimab Plus SOX/XELOX in Locally Advanced Gastric Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07685704Phase 2 · not yet recruiting Zanidatamab Combined With Chemotherapy as Neoadjuvant/Conversion Therapy for HER2-Positive (IHC 3+ or IHC 2+) Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: a Phase II Open-Label Study · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | HER2-Positive Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05709574Phase 2 · active not recruiting Tadalafil Effect + Chemotherapy in Resectable Gastric/GEJ Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07118176Phase 1 · active not recruiting Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05802056Phase 1 · active not recruiting Aldesleukin With Nivolumab and Standard Chemotherapy for Treatment of Gastric Cancer With Peritoneal Metastasis · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05836584Phase 2 · active not recruiting Testing Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastroesophageal Junction (GEJ) Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07139951Phase 2 · enrolling by invitation Hyperthermic Intraperitoneal Chemotherapy With Cisplatin and Paclitaxel for Gastric Cancer at High Risk of Peritoneal Recurrence · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07675967recruiting Clonal Hematopoiesis Chemotherapy and Radiation Effects Study · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04114136Phase 2 · recruiting Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06038578Phase 2 · recruiting A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07662005not yet recruiting Objective Sleep Characteristics and Neoadjuvant Immunotherapy Response in Gastric/GEJ Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07663786active not recruiting Evaluation of Esophagogastric Cancer Treatment With Nivolumab in Daily Clinical Practice · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07658872Phase 2 · not yet recruiting Perioperative Fruquintinib Combined With Sintilimab and SOX for Locally Advanced Gastric or GEJ Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05514717Phase 1 · terminated A Study of XMT-2056 in Advanced/Recurrent Solid Tumors That Express HER2 · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | HER2-Positive Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07655661Phase 2 · not yet recruiting Mannatide Combined With CAPOX and Tislelizumab for Advanced Gastric Cancer. · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05038254NA · active not recruiting Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07284186Phase 1 · recruiting First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05545293completed Prospective Study on Double-Stapling End-to-End Gastroduodenostomy Billroth-I Anastomosis in Laparoscopy-Assisted Surgery for Locally Advanced Distal Gastric Cancers · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05593458Phase 3 · recruiting Transarterial Neoadjuvant Chemotherapy vs.Traditional Intravenous Chemotherapy For Locally Advanced Gastric Cancer With SOX+PD-1 · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04739202Phase 2 · completed Personalized Targeted IMMUNOtherapy-based Regimens in Recurrent GASTric Adenocarcinoma (IMMUNOGAST) · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03823144NA · recruiting Intravital Microscopy in Human Solid Tumors · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07454642Phase 1 · recruiting AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07621562Phase 2 · not yet recruiting Tafolecimab Combined With Sintilimab and SOX in the Treatment of pMMR/MSS Gastric Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07607119NA · recruiting PULSAR Combined With Immunotherapy for Unresectable Locally Advanced Gastric Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07610629Phase 2 · not yet recruiting Retlirafusp Alfa Combined With Apatinib and Nab-Paclitaxel as Second-line Treatment for Gastric or Gastroesophageal Junction Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05955833NA · completed 89Zr-DFO*-Trastuzumab PET in Patients With Gastric or Breast Cancer - a Pilot Study · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | HER2-Positive Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05977998Phase 2 · recruiting A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07603349Phase 2/Phase 3 · not yet recruiting Adaptive Adjuvant Therapy After Neoadjuvant Therapy and Gastrectomy for Gastric or Gastroesophageal Junction Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07481357Phase 1 · recruiting A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal Adenocarcinoma · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07594548Phase 1 · not yet recruiting Futibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or Unresectable Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06251973Phase 2 · active not recruiting A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04314401active not recruiting National Cancer Institute "Cancer Moonshot Biobank" · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04736485Phase 2 · completed Perioperative Treatment in Resectable Gastric Cancer With Spartalizumab (PDR001) in Combination With Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel (FLOT) · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Cancer by AJCC v8 Stage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06862479enrolling by invitation Luso-Cor Stent Compared to Other Endoscopic Techniques for Management of Fistulas and Anastomotic Dehiscences(ES-LCCE-UDFM) · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04034251Phase 2 · terminated Intraperitoneal and Intravenous Paclitaxel Chemotherapy With Oral Capecitabine for Gastric Adenocarcinoma With Peritoneal Carcinomatosis · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04929015NA · suspended Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study) · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Gastric Cancer by AJCC v8 Stage | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05076279NA · active not recruiting Safety and Efficacy of Single or Reduced Ports Laparoscopic Gastrectomy for Advanced Gastric Cancer (SPACE-01) · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07007182Phase 2 · recruiting Conversion Therapy Plus Surgery and Radiotherapy for Retroperitoneal Nodal Metastases in Gastric Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07178808Phase 2 · recruiting PHASE II EVALUATION OF CYTOREDUCTION SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (CRS/HIPEC) IN GASTRIC CANCER · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07542652recruiting Association Between Microplastic Exposure and the Pathological Progression of Gastric Carcinogenesis · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06846346Phase 2 · recruiting Testing Ivonescimab in Combination With Chemotherapy in Advanced or Metastatic Gastric/Gastroesophageal Adenocarcinoma · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07551362Phase 1/Phase 2 · recruiting Dual-target CLDN18.2/HER2 CAR-NK Cells for Advanced Gastric/GEJ Cancer · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07551466recruiting AI Model for Early Gastric Cancer Diagnosis Using Endoscopic Imaging · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Early Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07353684Phase 2 · recruiting Adebrelimab Plus Apatinib Combined With SOX Regimen as Conversion Therapy for Gastric Cancer · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05969860Phase 2 · recruiting At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07533825NA · enrolling by invitation Laparoscopic Staging for Stage III Gastric Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03161522Phase 2 · recruiting Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04220827Phase 1 · active not recruiting Paclitaxel for the Treatment of Gastric or Gastroesophageal Cancer · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07529613Phase 1/Phase 2 · completed Trastuzumab Deruxtecan Plus Nivolumab Plus Capecitabine Plus Oxaliplatin for HER2 Low Gastric and Gastroesophageal Junction Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05567835Phase 2 · terminated A Study of Total Neoadjuvant Chemotherapy With FLOT VS Standard Perioperative FLOT in Patients With Gastric or GEJ Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05927857Phase 1/Phase 2 · recruiting Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second Line Metastatic Gastric Cancer . · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05034887Phase 2 · active not recruiting Phase 2 Study of Trastuzumab Deruxtecan in the Neoadjuvant Treatment, or Trastuzumab Deruxtecan Plus Capecitabine Plus Durvalumab(MEDI4736) in the Preoperative and Postoperative Adjuvant Treatment for Patients With HER2 Positive Gastric and Gastroesophageal Junction Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05753306Phase 2 · recruiting Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Peritoneal Metastasis, ROBO-CHIP Study · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05226169Phase 3 · recruiting Efficacy and Safety oF FErric CarboxymalTose in Patients With Advanced Gastric Cancer(EFFECT-AGC) · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06504615active not recruiting Observational Study of Patients Treated With Nivolumab and Chemotherapy for Advanced or Metastatic Esophageal, Gastroesophageal or Gastric Cancer in France · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07507071not yet recruiting Comparison of the Sensitivity of pCLE and Pathological Biopsy for Gastric Mucosal Lesions · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Early Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07507526Phase 2 · not yet recruiting A Study of Disitamab Vedotin, Tunlametinib, and PD-1 Antibody for Advanced Gastric Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05514769NA · recruiting Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty Versus Esophagogastric Anastomosis for Gastric Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Proximal Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02366819Phase 4 · suspended Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07481110recruiting Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Gastric Cancers in Algeria · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07312370Phase 4 · not yet recruiting Esomeprazole Plus Sucralfate for Post-ESD Ulcer Healing · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Early Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04007744Phase 1 · active not recruiting Sonidegib and Pembrolizumab in Treating Patients With Advanced Solid Tumors · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06408220NA · recruiting Risk Assessment Evaluation for Identifying Participants at High Risk for Stomach Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07139418recruiting The Clinical Significance of Examining Metastatic Lymph Nodes in Individual Gastric Mesenteries in the Patients With Gastric Cancer Undergoing Gastrectomy · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07453433completed Submucosal Pressure Ejection Endoscopic Dissection for Early Gastric Cancer: a Retrospective Cohort Study · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Early Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07447050Phase 2 · recruiting Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03686488Phase 2 · completed TAS 102 in Combination With Ramucirumab in Advanced, Refractory Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06532006Phase 3 · recruiting A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | HER2-Positive Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07438418not yet recruiting An Observational Study on Gastric Cancer in High-risk Individuals · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06896370recruiting An Observational Study for Gastric Cancer in Carriers of High Risk Helicobacter Pylori · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06943781recruiting Prospective Gastric Cancer Screening Using Helicobacter Pylori High-Risk Single Nucleotide Polymorphism Detection · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06943794NA · not yet recruiting Eradication of Helicobacter Pylori Subtypes at High Gastric Cancer Risk: a Cluster-randomized Controlled Trial · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06943807recruiting Prospective Gastric Cancer Screening With Fecal Multi-target DNA Analysis · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03997162active not recruiting Early Recovery After Surgery Protocol in Improving Quality of Life in Participants With Stage 0-IIIC Gastric Cancer Undergoing Surgery · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04430738Phase 2 · active not recruiting Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04907643NA · recruiting Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07405931NA · recruiting Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Early Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03008278Phase 1/Phase 2 · completed Olaparib and Ramucirumab in Treating Patients With Metastatic or Locally Recurrent Gastric or Gastroesophageal Junction Cancer That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06560645Phase 1 · terminated A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06370143recruiting A Study Collecting Health Information to Understand and Prevent Gastric Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04290806recruiting Registry Platform Gastric/Esophageal Cancer (SAPHIR) · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07371663Phase 1/Phase 2 · recruiting An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07266025Phase 2 · not yet recruiting Adebrelimab Combined With Induction Chemotherapy or SHR-8068 for Mismatch Repair-Deficient/Microsatellite Instability-High (dMMR/MSI-H) Locally Advanced Gastric/Gastroesophageal Junction Adenocarcinoma：A Randomized, Non-comparative Phase 2 Study · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04505553Phase 2 · completed Oral Cryotherapy Plus Acupressure and Acupuncture Versus Oral Cryotherapy for Decreasing Chemotherapy-Induced Peripheral Neuropathy From Oxaliplatin-Based Chemotherapy in Patients With Gastrointestinal Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07356466early Phase 1 · enrolling by invitation Clinical Efficacy of Pucotenlimab Combined With Lenvatinib and SOX Versus SOX Alone in Patients With HER2-Negative Advanced Gastric or Gastroesophageal Junction Adenocarcinoma · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03257163Phase 2 · active not recruiting Pembrolizumab, Capecitabine, and Radiation Therapy in Treating Patients With Mismatch-Repair Deficient and Epstein-Barr Virus Positive Gastric Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07332533Phase 2/Phase 3 · not yet recruiting A Study of KN026-based Combination Therapy in HER2-positive Gastric Cancer · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | HER2-Positive Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07334431Phase 1/Phase 2 · recruiting Fruquintinib Combined With Trastuzumab and XELOX as First-line Treatment in Patients With HER2-positive Advanced Gastric Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07312500active not recruiting Fecal DNA Methylation and Helicobacter Pylori SNPs Tests for Gastric Cancer · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06645808early Phase 1 · recruiting PET-imaging of Two Vartumabs in Patients With Solid Tumors · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07283848Phase 2 · withdrawn Zimberelimab + Domvanalimab in Gastroesophageal Adenocarcinoma · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03042169Phase 3 · terminated Surgical Resection Plus Chemotherapy Versus Chemotherapy Alone in Oligometastatic Stage IV Gastric Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03246516NA · completed Determinants of Patient Delay in Doctor Consultation in Oeso-gastric Cancers · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07059299Phase 1 · recruiting A Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab Plus FLOT for Resectable Esophagogastric Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07295002NA · not yet recruiting Sentinel Node Resection With or Without LECS After Noncurative ESD for EGC · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Early Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01048281recruiting Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Childhood Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07029269Phase 3 · recruiting Feasibility of Enhanced Recovery After Surgery Without Prophylactic Abdominal Drainage Tubes After Laparoscopic Distal Gastrectomy For Gastric Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07289997Phase 2 · recruiting Iparomlimab and Tuvonralimab Combined With Apatinib and Irinotecan Hydrochloride for the Treatment of Advanced Alpha-fetoprotein-producing Gastric Cancer (AFPGC) · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Gastric AFP-Producing Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06549816Phase 1 · completed A Study of SGN-B6A in Chinese Participants With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07263386Phase 2 · recruiting A Phase II, Multicenter, Randomized, Controlled Clinical Study Comparing the Efficacy and Safety of Sintilimab Plus SOX Versus SOX Alone as Adjuvant Therapy for PD-L1-Positive, Stage pN3 Gastric Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06333314Phase 2 · recruiting Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04779151Phase 2 · terminated Basket Trial Exploring the Efficacy and Safety of the Combination of Niraparib and Dostarlimab · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07252661Phase 1 · not yet recruiting Study of ACC-1898 in Adult Participants With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07253948recruiting Distribution Characteristics of Helicobacter Pylori · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Early Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07244471completed Water-injecting Endoscopic Submucosal Dissection for Early Gastric Cancer: a Retrospective Cohort Study · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | Early Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06328738Phase 1 · active not recruiting ELVN-002 With Trastuzumab +/- Chemotherapy in HER2+ Solid Tumors, Colorectal and Breast Cancer · condition mapped ALIAS · 586 trials mapped (240 active) | — | — | HER2-Positive Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06614439NA · completed PG Versus TG for Advanced PGC · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06675136Phase 1 · recruiting Nab-Paclitaxel PIPAC in Combination With Paclitaxel and Ramucirumab for the Treatment of Stomach Cancer With Peritoneal Metastases · condition mapped CURATED_BROADER · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07103668Phase 3 · recruiting A Phase III Randomized Study in CLDN18.2-positive Unresectable Locally Advanced Gastric Cancer Patients · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03819088NA · completed Effects on Quality of Life With Zinc Supplementation in Patients With Gastrointestinal Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04363801Phase 2 · terminated A Study of DKN-01 in Combination With Tislelizumab ± Chemotherapy in Patients With Gastric or Gastroesophageal Cancer · condition mapped ONTOLOGY_EXACT · 586 trials mapped (240 active) | — | — | Gastric Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |